| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Annexon Inc (NASDAQ: ANNX)
ANNX Technical Analysis
5
| As on 9th Jun 2023 ANNX STOCK Price closed @ 2.81 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 5.35 & Strong Sell for SHORT-TERM with Stoploss of 8.22 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ANNXSTOCK Price
| Open | 2.91 | Change | Price | % |
| High | 3.06 | 1 Day | -0.07 | -2.43 |
| Low | 2.79 | 1 Week | -0.04 | -1.40 |
| Close | 2.81 | 1 Month | -2.65 | -48.53 |
| Volume | 567167 | 1 Year | -10.22 | -78.43 |
| 52 Week High 13.25 | 52 Week Low 2.10 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ANNX Daily Charts |
ANNX Intraday Charts |
Whats New @ Bazaartrend |
ANNX Free Analysis |
|
|
ANNX Important Levels Intraday
| RESISTANCE | 3.33 |
| RESISTANCE | 3.16 |
| RESISTANCE | 3.06 |
| RESISTANCE | 2.96 |
| SUPPORT | 2.66 |
| SUPPORT | 2.56 |
| SUPPORT | 2.46 |
| SUPPORT | 2.29 |
ANNX Forecast April 2024
| 4th UP Forecast | 8.38 |
| 3rd UP Forecast | 6.59 |
| 2nd UP Forecast | 5.49 |
| 1st UP Forecast | 4.39 |
| 1st DOWN Forecast | 1.23 |
| 2nd DOWN Forecast | 0.13 |
| 3rd DOWN Forecast | -0.97 |
| 4th DOWN Forecast | -2.76 |
ANNX Weekly Forecast
| 4th UP Forecast | 5.84 |
| 3rd UP Forecast | 4.87 |
| 2nd UP Forecast | 4.27 |
| 1st UP Forecast | 3.67 |
| 1st DOWN Forecast | 1.95 |
| 2nd DOWN Forecast | 1.35 |
| 3rd DOWN Forecast | 0.75 |
| 4th DOWN Forecast | -0.22 |
ANNX Forecast2024
| 4th UP Forecast | 25.18 |
| 3rd UP Forecast | 18.01 |
| 2nd UP Forecast | 13.57 |
| 1st UP Forecast | 9.14 |
| 1st DOWN Forecast | -3.52 |
| 2nd DOWN Forecast | -7.95 |
| 3rd DOWN Forecast | -12.39 |
| 4th DOWN Forecast | -19.56 |
Annexon Inc ( NASDAQ USA Symbol : ANNX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ANNX Business Profile
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune and neurodegenerative diseases. It focuses on the treatment of body, brain, and eye disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated neurodegeneration. Its product candidates include ANX005, which has completed Phase 1b clinical trials to treat patients with guillain- barré syndrome; and ANX007, which has completed Phase 1b clinical trials to treat patients with glaucoma. The company's candidates also comprise ANX005 that has completed preclinical trials to treat patients with warm autoimmune hemolytic anemia, Huntington's disease, and amyotrophic lateral sclerosis; ANX007, which has completed preclinical trials for the treatment of geographic atrophy; and ANX009 that has completed preclinical trials for the treatment of systemic autoimmune diseases. The company was founded in 2011 and is headquartered in South San Francisco, California. Address: 180 Kimball Way, South San Francisco, CA, United States, 94080
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service